SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-018240
Filing Date
2020-09-23
Accepted
2020-09-23 17:00:38
Documents
10
Period of Report
2020-09-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43910
  Complete submission text file 0001493152-20-018240.txt   217402

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lctx-20200922.xsd EX-101.SCH 3195
3 XBRL LABEL FILE lctx-20200922_lab.xml EX-101.LAB 34591
4 XBRL PRESENTATION FILE lctx-20200922_pre.xml EX-101.PRE 22716
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3603
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12830 | Film No.: 201192584
SIC: 2836 Biological Products, (No Diagnostic Substances)